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Nickel ions from a corroded stent impact monocytes 1089cytometric surveillance and triggered apoptotic cell death. Although no significant changes in
Bcl-2 or Bax expressions were detected after 24 hours of Ni2þ treatment, increasing cleavage
of caspase-3 and -8 was present. Results showed that cleavage of caspase-8 was inhibited by
the presence of the inhibitor, Z-IETD-FMK, and this suggested the presence of Ni2þ-induced
U937 cell death through a death receptor-mediated pathway. Simultaneously, when treated
with a high concentration of Ni2þ ions, expressions of the vascular remodeling factors, matrix
metalloproteinases (MMP)-9 and -2, were activated in dose- and time-dependent manners.
Secretion of the proliferative factor, monocyte chemoattractant protein (MCP)-1, significantly
increased during the first 6 hours of incubation with 480 mM Ni2þ-treated medium.
Conclusion: Our results demonstrated that a high concentration of Ni ions causes apoptotic cell
death of circulating monocytes. They may also play different roles in vascular remodeling dur-
ing the corrosion process following implantation of Ni alloy-containing devices.
Copyright ª 2014, Elsevier Taiwan LLC & Formosan Medical Association. All rights reserved.Introduction
Most physicians are reluctant to believe that current car-
diovascular stents can corrode in the high-chloride envi-
ronment of the human cardiovascular system and the
release of nickel (Ni) ions might influence human homeo-
stasis milieu. In 2000, two research teams1,2 simultaneously
warned that explanted stenting devices from the EUROSTAR
registry trials for abdominal aortic aneurysm repair
demonstrated severe corrosion in the platinum marker area
and also at random positions of the metallic frame.
Corrosion consisted of pits of various sizes, with irregularly
shaped craters, larger defects of cracks, and even total
failure with complete disintegration of the explanted stents
according to a scanning electron microscopic analysis.
Additionally, through an energy dispersive X-ray (EDAX)
analysis of irregular surfaces due to metal corrosion, a
decrease in the Ni concentration in the center of a defect,
compared to the surrounding normal segment, confirmed
that Ni ions were being released after initiation of corro-
sion.1,2 Ni-containing alloys are often used in biomedical
applications such as dental and orthopedic prostheses and
cardiovascular stents. Stents and stent-grafts of Ni-
containing alloys (for example, nitinol and 316L stainless
steel) have clinically been used to treat coronary athero-
sclerosis, peripheral arterial occlusive disease, and aortic
aneurysms for more than a decade. Among the physical,
chemical, and electrochemical properties of Ni-containing
alloys, corrosion of nitinol wire,1,2 also confirmed for 316L
stainless steel,3 was reported in extracted devices with
local accumulation of degraded products (especially Ni)
released by the corrosion process. Cell-induced electro-
chemical corrosion and active cellular destruction of sur-
faces may potentially play roles in the corrosion of stent
metals and deserve further investigation.
Although the restenosis rate after interventional stent-
ing for coronary arterial disease has been significantly
reduced compared to the previous method of using only
balloon angioplasty,4,5 the mechanism of restenosis is
complicated and not fully understood. Boyle6 first claimed
that monocytes and/or macrophages were involved in this
process and may influence the thickness of restenosis. An
increase in circulating monocytes after coronary in-
terventions was also demonstrated by Fukuda et al.7 Theirstatements implied an important role for monocytes in the
process of vascular remodeling after vascular injury and
stent intervention.
Impacts of Ni ions released from corroded stents and stent
grafts on the behaviors of monocytes and macrophages are
still not well understood. Several studies reported that Ni
ions can induce in vitro tissue inflammation at subtoxic
concentrations through direct activation ofmonocytes (THP-
1)8 and cause secretion of the inflammatory cytokines,
interleukin (IL)-1b, IL-6,9 IL-810 and tumor necrosis factor
(TNF)-a, from monocytes (THP-1) in vitro.11 Additionally, Li
et al12 had demonstrated that Ni2þ ions may induce the
changes in inflammatory cytokines secretion from mono-
cytes. Few reports so far, however, have properly focused on
the relationship between Ni released by the corrosion pro-
cess and monocyte activation. In this study, the relationship
between leached Ni concentrations and monocyte behavior
was explored. The concentration of Ni2þ ionswas reported to
be 260 mM (14.4 ppmZ 261 mM) after short-term corrosion of
Ni-containing alloys and 0.5 mM after long-term corrosion
in vitro.13,14 Half of murine T cell hybridoma cells died of
apoptosis after 24 hours when exposed to Ni (II) acetate at
480 mM.15 In order to explore the effects of Ni concentrations
from corroded Ni-containing alloys on monocyte behavior, a
human promonocytic cell line, U937, was cultured with
graduated concentrations of Ni2þ (0 mM, 50 mM, 240 mM, and
480 mM) in vitro, while also monitoring the cytotoxicity and
inflammatory activation of U937 cells.Materials and methods
Cell culture
Human promonocytic (macrophage-like) U937 cells were
obtained from American Type Culture Collection (Manassas,
VA, USA). Cells weremaintained in RPMI 1640medium (Gibco
BRL, Rockville, MD, USA) with 2 mM L-glutamine adjusted to
contain 1.5 g/L sodium bicarbonate, 4.5 g/L glucose, 10 mM
hydroxyethyl piperazineethanesulfonic acid (HEPES),
1.0 mM sodium pyruvate, 10% fetal bovine serum, 100 units/
mL penicillin, and 100 mg/mL streptomycin (Gibco 15140-
122, Rockville,MD,USA) at 37 C, in an atmosphere of 5%CO2.
Cells were passaged when they became confluent every 4e5
1090 C.-M. Shih et al.days. For each experiment, cells were seeded in T25 flasks in
serum-free medium. The density was not allowed to exceed
106 cells/mL, and Ni (II) chloride solutions (anhydrous pow-
der purchased from Sigma-Aldrich, St. Louis, MO, USA) were
added 24 hours later. After being incubated for the indicated
time, the cell suspension was centrifuged to obtain cells and
supernatants for further analyses.
Enzyme-linked immunosorbent assay
Cell cultures were transferred to centrifuge tubes and
centrifuged at 2000  g for 10 minutes. Supernatants were
tested for monocyte chemoattractant protein (MCP)-1 and
IL-8 with enzyme-linked immunosorbent assay (ELISA) kits
(Pierce Endogen, Woburn, MA, USA) in strict accordance
with the manufacturer’s instructions. Results are expressed
as a percentage relative to the group without treatment to
yield comparable data.
Gelatin zymography
Supernatants were collected by centrifugation of cell pellets
and concentrated with an Amicon Ultra-4 centrifugal filter
device (Millipore, Bedford, MA, USA). Concentrated super-
natants with equivalent amounts of protein were mixed with
2 Laemmli sample buffer [2% sodium dodecylsulfate (SDS),
62.5 mM Tris-HCl at pH 6.8, 25% glycerol, and 0.01% bromo-
phenol blue (Bio-Rad, Hercules, CA, USA)] for 10 minutes at
room temperature, then electrophoresed on 10% SDS-
polyacrylamide gel electrophoresis (PAGE) containing 10%
gelatin. Gels were washed with 2.5% Triton X-100 to remove
SDS for 30 minutes at room temperature, equilibrated in
1  Zymogram developing buffer (50 mM Tris-HCl, 5 mM
CaCl2, 0.2 M NaCl, and 0.02% Brij) for 30 minutes at room
temperature with gentle agitation, then incubated in fresh
1  Zymogram developing buffer for 24 hours at 37 C. Gels
were subsequently stained with Coomassie blue R-250 for 30
minutes, followed by destaining (50% methanol and 10%
acetic acid) until an optimal contrast was achieved with the
lytic bands. Gels were dried, scanned, and analyzed by
densitometry using Image-Pro Plus software (National In-
stitutes of Health, Bethesda, MD, USA).
Flow cytometric analysis
Cells were collected, fixed with 70% alcohol, and stained
with propidium iodide (PI) for dead cell analysis or with PI/
Triton X-100 for cell cycle analysis using the Cycletest Plus
DNA Reagent Kit (Becton Dickinson, San Jose, CA, USA) in
accordance with the manufacturer’s instructions. Cells
were then subjected to flow cytometry with the percent-
ages of cells in different phases of the cell cycle calculated
from DNA histograms. Cells with sub-G1 DNA content were
considered apoptotic cells.
Terminal deoxynucleotidyl transferase dUTP nick
end labeling assay
The assay was performed using the terminal deoxy-
nucleotidyl transferase (TdT) dUTP nick end labeling
(TUNEL) method with an In Situ Cell Death Detection Kit,Fluorescein (Roche Diagnostics, Mannheim, Germany).
Following the experiments, cells were collected, washed
twice with phosphate-buffered saline (PBS), and fixed with
4% paraformaldehyde for 10 minutes at room temperature.
Fixed cells were washed three times with PBS, treated with
0.1% Triton X-100 in 0.1% sodium citrate solution for 2 mi-
nutes on ice, then washed twice with PBS again. Cells
treated with the TUNEL mixture were incubated at 37 C in
a dark, humidified environment for 1 hour after the TUNEL
reaction mixture was added. Upon completion of incuba-
tion, treated cells were washed three times with PBS,
counterstained with 40,6-diamidino-2-phenylindole (DAPI),
and evaluated using flow cytometry.
DNA ladder assay
Cells were collected by centrifugation and washed with ice-
cold PBS. DNA from cells was extracted using the AxyPrep
Multisource Genomic DNA Miniprep Kit (Oxygen, Pittsburgh,
PA, USA) and precipitated with ethanol. After drying, DNA
samples were dissolved in TE buffer at pH 7.8 (Tris-HCl
10 mmol/L at pH 7.4 and EDTA 1 mmol/L at pH 8.0) and
quantitated. DNA (2 g) was separated on 2% agarose gels at
100 V for 80 minutes. Ladders of DNA were detected by
staining with ethidium bromide.
Western blot analysis
Nuclear and cytoplasmic protein extracts were purified
using Pierce (Rockford, IL, USA) NE-PER nuclear and cyto-
plasmic extraction reagents according to the manufac-
turer’s instructions. Protein concentrations were
determined with a Coomassie Plus Protein Assay Reagent
Kit (Pierce, Rockford, IL, USA) using bovine serum albumin
as the standard. Equal amounts of protein were separated
on SDS polyacrylamide gels, transferred to polyvinylidene
difluoride membranes, and blocked in 5% nonfat milk
buffer. Membranes were probed using the following primary
antibodies and dilutions: anti-poly ADP-ribose polymerase
(PARP) (monoclonal, 1:1000; Calbiochem, San Diego, CA,
USA); anti-caspase-3 (polyclonal, 1:500; Cell Signaling,
Rockford, IL, USA); anti-Bcl-2 (monoclonal, 1:1000; MBL,
Woods Hole, MA, USA); anti-Bax (polyclonal, 1:400; Cal-
biochem, San Diego, CA, USA); anti-caspase-8 (polyclonal,
1:200; Chemicon, Single Oak Drive Temecula, CA, USA),
anti-histone H1 (monoclonal, 1:500; Upstate Biotechnology,
Lake Placid, NY, USA), and anti-a-tubulin (monoclonal,
1:2000; Sigma-Aldrich, St. Louis, MO, USA). After washing,
membranes were incubated with secondary antibodies
(1:5000, Amersham Pharmacia Biotech, La Jolla, CA, USA).
Reactions were developed by enhanced chemiluminescence
(Amersham Pharmacia Biotech, La Jolla, CA, USA), and
images were obtained by exposure to X-ray film.
Immunofluorescence
Cells were washed with PBS, fixed with 4% paraformaldehyde
for 20minutes at roomtemperature, andwashed twice inPBS.
Cells were thenmounted by cytospinning, permeabilizedwith
0.2%TritonX-100 for 2minutesat roomtemperature, and then
washed with PBS again. A tyramide signal amplification kit
Nickel ions from a corroded stent impact monocytes 1091(T20922, Invitrogen, Carlsbad, CA, USA) was used to deter-
mine the immunofluorescence. Endogenous peroxidase ac-
tivity was quenched by treatment with 3% H2O2 in PBS for 10
minutes. Cells were then incubated with 1% blocking reagent
in PBS for 60minutes at room temperature and labeled with a
monoclonal rabbit anticleaved-caspase-3 antibody (9664, Cell
Signaling, Rockford, IL, USA) diluted in blocking buffer for 50
minutes at room temperature. Cells were incubated with a
goat anti-rabbit immunoglobulin G-horseradish peroxidase
conjugate, diluted in blocking buffer for 30 minutes at room
temperature, treated with green fluorescent-labeled tyr-
amide working solution, and mounted with DAPI medium as
instructed.
Statistical analysis
All data are expressed as the mean  standard error of the
mean (SEM). The difference in mean values among different
groups was analyzed by a one-way analysis of variance
(ANOVA). A value of p < 0.05 was considered statistically
significant.
Results
Ni2D increased MCP-1 and matrix
metalloproteinase production by U937 cells
Monocytes secrete various inflammatory factors including
cytokines, chemokines, and leukotrienes, which can acti-
vate or modulate inflammatory reactions. When treated
with Ni2þ at a concentration of 480 mM, secreted MCP-1
harvested from the supernatant significantly increased in
the medium during the first 3e6 hours. After 12 hours,
however, the difference gradually became insignificant
(Fig. 1A). Interestingly, treatment with 240 mM and 480 mM
Ni2þ significant decreased MCP-1 production after 24 hours
of exposure. Matrix metalloproteinases (MMPs) are a group
of enzymes in the extracellular matrix (ECM) and areFigure 1 Ni2þ increased monocyte chemoattractant protein (MCP
U937 cells. (A) U937 cells treated with 50e480 mM NiCl2, and MCP
immunosorbent assay (ELISA). Results are the average of four inde
tive to the control group (without treatment). At the same time po
240 mM, and 480 mM NiCl2. Data are expressed as the mean  SEM, *
treated with NiCl2 as indicated. Culture medium was collected a
analyzed by gelatin zymography.involved in a variety of physiologic processes including
inflammation and remodeling of vascular injury. By means
of gelatin zymography, analyzing the activities of MMP-2
and -9 from the supernatant revealed a significant in-
crease in the expression of MMP-9 when U937 cells were
treated for more than 6 hours with 240 mM and 480 mM Ni2þ
(Fig. 1B). Additionally, variations in MMP-2 activity after
treatment with Ni2þ were significant with 6e24 hours of
treatment. These results implied that expressions of MCP-1
and MMP-9 in the supernatant were aroused and augmented
when U937 cells proceeded to apoptotic cell death under
treatment with a high concentration of Ni2þ.
Ni2D caused cell death in dose- and time-
dependent manners in U937 cells
To understand the detrimental effects of Ni on monocytes,
U937 cells were treated with different concentrations of
Ni2þ for 24 hours at 37 C. Experimental results showed that
Ni2þ induced U937 cell death with a dose-dependent effect
(Fig. 2A). U937 cells were then treated with Ni2þ for
different durations. Cells were harvested, fixed with 70%
alcohol, stained with PI, and analyzed by flow cytometry.
Significant cell death occurred after 24 hours in 240 mM
Ni2þ-treated cultured medium and after just 6 hours in
480 mM Ni-treated cultured medium. After 6 hours of in-
cubation in 480 mM Ni2þ-treated medium, about 25% of
monocytic cells had died (Fig. 2B).
Ni2D induced apoptotic cell death of U937 cells
The next step was to determine which mode of cell death
was activated by Ni ions. Ni2þ at 240 mM and 480 mM was
found to have significantly increased the proportion of dead
cells from 6.8  1.2% (control) to 24.3  3.0% (240 mM) and
43.7  3.6% (480 mM) (Fig. 3A), whereas TUNEL-positive
cells increased from 6.4  0.7% to 32.0  3.7% (240 mM)
and 50.8  3.7% (480 mM) (Fig. 3B). The DNA ladder assay)-1 secretion and matrix metalloproteinase (MMP) production by
-1 in conditioned medium were analyzed by an enzyme-linked
pendent experiments and are expressed as a percentage rela-
int, bars 1e4, respectively, indicate treatment with 0, 50 mM,
p < 0.05 indicates a significant difference. (B) U937 cells were
t the indicated time points. Activities of MMP-2 and -9 were
Figure 2 NiCl2 induced cell death in dose- and time-dependent manners in U937 cells. (A) U973 cells were treated with NiCl2 at
the indicated concentrations for 24 hours, and observed with an inverted microscope at 40  magnification. Representative images
are shown. The bar indicates 100 mm. (B) U973 cells were treated with NiCl2 at the indicated concentrations and time points, then
stained with propidium iodide. Cells were subjected to a flow cytometric analysis. The cell viability of U937 cells is expressed as a
percentage of the control group in four independent experiments. Data are expressed as the mean  SEM, and * p < 0.05 indicates a
significant difference.
1092 C.-M. Shih et al.also showed a positive result after 240 mM Ni2þ treatment
for 24 hours and 480 mM Ni2þ treatment for 6 hours
(Fig. 3C). These results indicated that Ni ions could cause
cell death by an apoptotic mechanism in U937 cells when
the Ni concentration reached 240 mM or higher.Ni2D induced U937 cellular death through a death
receptor-mediated pathway
There are two pathways in the apoptotic mechanism:
mitochondrion- and death receptor-mediated pathways. Inorder to determine which pathway was mediated by Ni
ions, expressions of proteins related to apoptosis (caspase-
8 and -3, Bcl-2, Bax, and PARP) were checked. Additionally,
according to Western blotting, densitometry was used to
quantify the relative activation/expressions of caspase-8,
-3, Bcl-2, Bax, and PARP. We demonstrate that significant
activation of caspase-8 41/43 kDa was found with 240 mM
and 480 mM of Ni2þ treatment (Fig. 4A and D). Similar
changes were also observed in downstream proteins,
caspase-3 and PARP. Expressions of pro-caspase-3 (35 kDa)
in the cytosol (Fig. 4A and E) and full-length PARP (115 kDa)
in nuclei (Fig. 4C and F) decreased, whereas expressions of
Figure 3 NiCl2 induced apoptotic cell death in U937 cells. (A) U937 cells were treated with NiCl2 at the indicated concentrations
for 24 hours. Cells were fixed with 70% alcohol, and stained with propidium iodide/Triton X-100. A cell cycle analysis of the cellular
DNA content was conducted by flow cytometry. The number in each panel refers to the mean percentage of cells in the M1 region.
Quantitative results from three independent experiments are shown in the right graph. (B) U937 cells were treated with NiCl2 for 24
hours. Apoptotic cells were determined by a terminal deoxynucleotidyl transferase (TdT) dUTP nick end labeling (TUNEL) assay and
examined by flow cytometry. The number in each panel refers to the mean percentage of cells in the M2 region. Quantitative results
from three independent experiments are shown in the right graph. * p < 0.05 indicates a significant difference from the group
without treatment. (C) Agarose gel electrophoresis of DNA extracted from U937 cells after treatment with 240 mM or 480 mM NiCl2
for different durations.
Nickel ions from a corroded stent impact monocytes 1093cleaved caspase-3 (17 kDa and 19 kDa) and PARP (85 kDa)
increased after treatment with 240 mM and 480 mM Ni2þ. By
means of immunofluorescence, cleaved caspase-3 was
located in the cytoplasm and also in nuclei. Cleaved
caspase-3 significantly increased (white arrow) with the Ni
concentration (Fig. 4B). This effect was blocked by pre-
treatment with 100 mM Z-IETD-FMK, an inhibitor of caspase-
8. By contrast, expressions of Bcl-2 (Fig. 4A and G) and Bax
(Fig. 4A and H), members of the mitochondrial pathway,
showed no obvious differences after treatment withdifferent concentrations of Ni2þ. These results indicated
that the death receptor pathway mediated Ni2þ-induced
U937 cell apoptosis.Discussion
Ni-containing stents have been used in cardiovascular ap-
plications including atherosclerosis and aneurysms for a
long time. Ni-containing alloys are known to be allergenic
Figure 4 Death receptor pathway mediated Ni2þ-induced U937 cell apoptosis. (A) U937 cells were treated with 50e480 mM NiCl2
for 24 hours, and lysates of the cytosolic fraction were collected and subjected to an immunoblot analysis with anti-caspase-8, -3,
anti-Bcl-2, and anti-Bax antibodies. a-Tubulin was used as a loading control. (B) U937 cells were pretreated with or without 100 mM
Z-IETD-FMK for 1 hour, and then treated with 480 mM NiCl2 for 24 hours. After being prepared and mounted by cytospinning, cells
were stained with an anticleaved caspase-3 antibody and counterstained with 40,6-diamidino-2-phenylindole (DAPI). Representa-
tive images are shown. The bar represents 100 mm. (C) U937 cells were treated with 50e480 mM NiCl2 for 24 hours. The nuclear
fraction was collected and subjected to an immunoblot analysis with an anti-poly ADP-ribose polymerase (PARP) antibody. Nucleus
histone H1 was used as a loading control. (DeH) According to Western blotting, densitometry was used to quantify the relative
activation/expressions of caspase-8, -3, Bcl-2, Bax, and PARP. Quantitative results are from three independent experiments, and
results are expressed as the mean  SEM. * p < 0.05 was considered statistically significant.
1094 C.-M. Shih et al.and carcinogenic,16e18 and to have toxic potential19,20
after being implanted in vivo. These phenomena were
observed in our animal study in which 316L stainless steel
stents were explanted from an iliac arterial segment of
New Zealand white rabbits after 4 weeks of implantation.21
The Ni concentration diminished from 14% to 6% as detec-
ted by EDAX. The lower Ni concentration indicates the
possibility of a leaching process during formation of
corrosion pits after implantation. The corrosion process of
implanted stents could cause high local concentrations of
Ni around the stents. It was also shown that theconcentration of Ni ions was as high as 240 mM from a short-
term corrosion process when Ni-containing alloys were
immersed in cell-culture medium for 3 days and 0.5 mM
from long-term corrosion.13,14 Subtoxic Ni concentrations
can activate monocytes and induce inflammatory reactions
in vitro.8 Fukuda et al7 showed that the increased circu-
lation of monocytes with a peak monocyte count was
related to the in-stent neointimal volume after coronary
stent implantation. This was suggestive of monocyte
involvement in the remodeling process after vascular
injury.
Nickel ions from a corroded stent impact monocytes 1095In this study, we demonstrated that Ni ions can activate
U937 monocyte cells and promote the release of MCP-1 and
IL-8 after exposure to a high concentration of Ni ions
(480 mM), resulting in apoptotic cell death. MCP-1 is one
of the molecules responsible for monocyte/macrophage
infiltration and activation. Blockade of MCP-1 attenuated
neointimal formation and produced negative remodeling in
different animal models.22,23 Indeed, it has been reported
that Ni ions activate the monocytic inflammatory responses
via the Nrf2 signaling pathway24 and the Nuclear Factor-
Kappa B (NF-kB)-mediated pathway12. Additionally, Ni ions
have broad-based effects on lipopolysaccharide-induced
cytokines secretion pathways in monocytes.25 Our results
revealed that a high concentration of Ni ions from corrosion
activated some monocytes in the short term. Monocytes
quickly proceeded to apoptotic cell death through a death
receptor pathway, while the level of MCP-1 gradually
decreased in the medium. Monocytes may thus have a
negative remodeling effect under high concentrations of Ni.
At the same time, MMP-9 activity also significantly
increased, possibly due to activation by incremental MMP-9
secretion and/or release from dead U937 monocyte cells.
Wan et al26 demonstrated that exposure of Ni2þ ions may
induce the accumulation of hypoxia inducible factor-1a
(HIF-1a), resulting in MMP-2 and MMP-9 production in
human monocytic cells. Remodeling of the ECM increased
due to higher activity of MMPs, especially MMP-9. The net
effect was thus negative. This may therefore contribute to
the better result on the restenosis rate of coronary stents
compared to balloon angioplasty. By contrast, plasma MMP-
9 levels were significantly higher in patients with an
abdominal aortic aneurysm.27 MMP-9 may have clinical
value as an enzymatic marker for endoleakage after
endovascular abdominal aortic aneurysm (AAA) exclusion.28
This correlates with an increase in MMP-9 activity after Ni
treatment in our results. Endoleakage or migration may
occur if higher MMP activity is found during the early stage
of stent graft implantation. Clinically, there are many kinds
of Ni-containing alloys and stents. The diverse compositions
of metals in different stents may result in different con-
centrations of Ni from corrosion and various responses from
monocytes after stenting.21
In addition to the impact on monocytes, Ni ions also have
persistent inflammatory effects on increasing of cytokines
and CC chemokines which are involved in pulmonary
inflammation.29 The Ni ions may facilitate the production of
IL-830 and IL-1231 by signals from toll-like receptor 4
(TLR4)/ation protein 2 (MD2)-mediated p38 mitogen-acti-
vated protein kinase (MAPK), NF-kB, and interferon regu-
latory factor 1 (IRF-1) activation in dendritic cells. Exposure
of U937 cells to the Ni ions can cause increased levels of
lipid peroxides and decreased levels of glutathione, a kind
of antioxidant.32 Similarly, Ni ions also induce endothelial
disturbance through inhibition of endothelial nitric oxide
synthase dimerization, which is mediated by an oxidative
stress-dependent pathway.33 Ni ions contribute to the sys-
temic and extensive effects in inflammation. Therefore, an
in depth study of the physiological effects of Ni ions is
necessary in the future.
There are some limitations to this study. The use of the
U937 cell line was clearly a compromise in our study,
because U937 cells continuously divide whereas peripheralblood monocytes do not. Furthermore, the remodeling
process is very complicated and involves many kinds of
cells, cytokines, and growth factors. An animal model is
thus necessary for an in vivo study to verify the behavior of
monocytes exposed to Ni-containing stents used in this
in vitro study.
In conclusion, our results showed that the behavior of
monocytes depended on the concentration of Ni ions. A
high concentration of Ni ions may increase the production
of MCP-1 and MMP in monocytes. By contrast, Ni ions also
induce apoptosis in monocytes, through caspase-8, -3 and
PARP-mediated pathways. Toxic and subtoxic concentra-
tions will cause different responses and reactions by
monocytes followed by different effects on vascular
remodeling. Furthermore, because the concentration of Ni
ions goes down with time after stent graft implantation,
this complicates the net effect, making the final results
difficult to predict.
Currently, there are many kinds of stents used in the
clinic. They are manufactured from 316L stainless steel
(Type 316 is an austenitic chromium Ni stainless steel con-
taining molybdenum; Type 316L is an extra-low carbon
version of Type 316 that minimizes harmful carbide precip-
itation due to welding, which contains 10e14% Ni) or L-605
cobalt chromium alloy (the major alloying elements are as
follows: 50% cobalt, 20% chromium, 15% tungsten, and 10%
Ni) material. Even though the industries and merchants
claim that allergy to 316L stainless steel or L-605 cobalt
chromium alloy of implants is extremely rare, scientists are
still worried about the damage which may occur by the
releasing of Ni. The stent may be manufactured from a
bioresorbable vascular scaffold, which is a trend which may
be applied in the future. The traditional drug-eluting stent is
coated with an antiproliferative drug on the inner and outer
surface of the entire stent; approximately 80e90% of the
coated drug may be released after a period of time. The
delivery device (durable polymer) on the surface of the stent
is nonresorbable and the coated drugs will be existed. This
perhaps will induce the secondary vascular intimal hyper-
plasia and lead to late phase thrombosis, as well as cardiac
events. Patients may require lifelong anticoagulation
treatment. A period of 6e9 months after implantation of the
biodegradable polymer drug eluting stent in patients, the
main delivery device (biodegradable polymer) on the sur-
face of the stent, which is used to carry drugs, will be
completely absorbed and converted into water and carbon
dioxide in the human body. Therefore, it will become a bare
metal stent, avoiding the complication of late thrombosis
and severe cardiac events, which may result from stopping
dual-antiplatelet therapy in traditional drug-eluting stent
implanted patients. According to the structure, the back-
bones of resorbable vascular scaffold stents are still manu-
factured from 316L stainless steel or L-605 cobalt chromium
alloy material. Prior to finding materials to replace 316L
stainless steel or L-605 cobalt chromium alloy material, the
systemic damage from Ni is still worthy of our attention.Acknowledgments
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